Car accidents, falls, and sports-related collisions are among the many causes of traumatic brain injuries (TBI)—sudden impact that damages the brain. Such injuries can affect cognitive functioning including information ...
Jul 28, 2022
0
4
Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to ...
Jul 26, 2022
0
6
Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats. Children are at higher risk for health changes due to these impacts for a range ...
Jun 15, 2022
0
5
T cells are usually good at eliminating diseased cells, but they seem to fail when it comes to tumor cells. In JCI Insight, MDC teams led by Armin Rehm and Uta Höpken describe what inhibits this immune function, and how ...
Jun 13, 2022
0
21
Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to ...
Jun 13, 2022
0
15
A group of researchers at Children's Hospital of Philadelphia (CHOP), in collaboration with Beam Therapeutics, have tested and developed an "off-the-shelf" chimeric antigen receptor T-cell (CART) using base editing, which ...
May 23, 2022
0
25
Almost 1 billion children and adults with disabilities, and older people, are unable to access the assistive technology they need, according to a UN report, which calls for more investment in these life-changing products.
May 18, 2022
0
1
In the fight against cancer, a new tool has emerged that's shifted the treatment landscape. CAR T-cell therapy, first approved for clinical use in 2017, uses a patient's own re-engineered immune cells to attack cancer. It ...
May 17, 2022
0
14
A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida and Case Western, Cleveland Medical Center, investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma ...
May 12, 2022
0
18
Massachusetts General Hospital (MGH) researchers have developed a novel treatment strategy that has the potential to bring the life-saving benefits of chimeric antigen receptor T-cell therapy (CAR T) to patients with acute ...
Apr 28, 2022
0
5
